Interleukin-17 blockade in generalized pustular psoriasis - new hope for severely ill patients
Author:
- 16 March 2017
- journal article
- editorial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (3) , 572-573
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label studyBritish Journal of Dermatology, 2016
- Rebound pustular psoriasis after brodalumab discontinuationBritish Journal of Dermatology, 2016
- Anti-interleukin-17 treatment of psoriasisJournal of Dermatological Treatment, 2016
- Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasisJournal of the European Academy of Dermatology and Venereology, 2014